Full Text (PDF)
Review Article

Artificial Intelligence in Pharmaceutical Research and Development: From Target Identification to Clinical Applications

R. Vinoth, D. Senthil Rajan, A. Nandhini, M. Tamizharasu, D. Rajeswari

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Journal of Pharmaceutical and Medicinal Chemistry 11(2):p 51-62, July - Dec. 2025. | DOI: https://doi.org/10.21088/jpmc.2395.6615.11225.2

How Cite This Article:

R. Vinoth, D. Senthil Rajan, A. Nandhini et al. Artificial Intelligence in Pharmaceutical Research and Development: From Target Identification to Clinical Applications. J Pharmaceut Med Chem. 2025; 11(2): 51-62.

Timeline

Received : August 13, 2025         Accepted : November 18, 2025          Published : December 30, 2025

Abstract

Artificial Intelligence (AI) is emerging as a transformational technique in pharmaceutical research and development, enabling the shift from conventional experimental approaches to predictive, data-driven methodologies. This review is a comprehensive overview of the use of AI in the drug development pipeline, such as identifying targets, discovering hits, lead optimization, preclinical trials, clinical trials, and post-marketing surveillance. Machine learning, deep learning, natural language processing, and generative models are advanced methods that assist the integration of data on a multi-dimensional basis and make decisions about data DSSs more efficient. Despite the challenges related to data quality, interpretability, and regulatory compliance, AI demonstrates significant potential in improving translational success and accelerating therapeutic innovation towards precision and patient centric healthcare.


References

  • 1.   Askin S, Burkhalter D, Calado G, Dakrouni SE. Artificial Intelligence Applied to clinical trials: opportunities and challenges. Health technology. 2023. doi:10.1007/S12553-023- 00738-2
  • 2.   Ali KA, Mohin S, Mondal P, Goswami S, Ghosh S, Choudhuri S. Influence of artificial intelligence in modern pharmaceutical formulation and drug development. Future Journal of Pharmaceutical Sciences (Print). 2024. doi:10.1186/S43094-024-00625-1
  • 3.   Bhatia N, Khan MMU, Arora S. The Role of Artificial Intelligence in Revolutionizing Pharmacological Research. Current Pharmacology Reports. 2024. doi:10.1007/ S40495-024-00367-X
  • 4.   Bhatt P, Singh S, Kumar V, Nagarajan K, Mishra SK, Dixit PK, et al. Artificial Intelligence in Pharmaceutical Industry: Revolutionizing Drug Development and Delivery. The Chinese Journal of Artificial Intelligence. 2023. doi:10.2 174/0129503752250813231124092946.
  • 5.   Bhattamisra SK, Banerjee P, Gupta P, Mayuren J, Patra S, Candasamy M. Artificial Intelligence in Pharmaceutical and Healthcare Research. Big Data and Cognitive Computing. 2023. doi:10.3390/BDCC7010010.
  • 6.   Boniolo F, Dorigatti E, Ohnmacht AJ, Saur D, Schubert B, Menden MP. Artificial intelligence in early drug discovery enabling precision medicine. Expert opinion on drug discovery. 2021. doi:10.1080/17460441.2021.1918096.
  • 7.   Chen H, Lu DX, Xiao Z, Li S, Zhang W, Luan X, et al. Comprehensive applications of the artificial intelligence technology in new drug research and development. Health Information Science and Systems. 2024. doi:10.1007/ S13755-024-00300-Y.
  • 8.   Chen W, Liu X, Zhang S, Chen S. Artificial intelligence for drug discovery: Resources, methods, and applications. Molecular Therapy: Nucleic Acids. 2023. doi:10.1016/J. OMTN.2023.02.019.
  • 9.   Chen Z, Liu X, Hogan WR, Shenkman E, Bian J. Applications of artificial intelligence in drug development using real-world data. Drug Discovery Today. 2021. doi:10.1016/J. DRUDIS.2020.12.013.
  • 10.   Chinnaiyan K, Mugundhan SL, Narayanasamy D., Mohan M. Revolutionizing Healthcare and Drug Discovery: The Impact of Artificial Intelligence on Pharmaceutical Development. Current Drug Therapy. 2024. doi:10.2174/011 5748855313948240711043701.
  • 11.   Chopra H, Baig AA, Gautam RK, Kamal MA. Application of Artificial intelligence in Drug Discovery. Current pharmaceutical design. 2022. doi:10.2174/1381612828666220608141049
  • 12.   Colombo S. Applications of artificial intelligence in drug delivery and pharmaceutical development. Elsevier eBooks. 2020. doi:10.1016/B978-0-12-818438-7.00004-6
  • 13.   Dermawan D, Alotaiq N. From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes. Pharmaceuticals. 2025. doi:10.3390/ PH18070981
  • 14.   Frusciante L, Visibelli A, Geminiani M, Santucci A, Spiga O. Artificial Intelligence approaches in drug discovery: Towards the laboratory of the future. Current topics in medicinal chemistry. 2022. doi:10.2174/1568026622666221006140825
  • 15.   Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P. Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Molecular diversity. 2021. doi:10.1007/S11030-021-10217-3
  • 16.   Han R, Yoon H, Kim G, Lee H, Lee Y. Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery. Pharmaceuticals. 2023. doi:10.3390/PH16091259
  • 17.   Hassan-Farghali, Canová NK, Arora M. The potential applications of artificial intelligence in drug discovery and development. Physiological Research. 2021. doi:10.33549/ PHYSIOLRES.934765
  • 18.   Husnain A, Rasool S, Saeed A, Hussain HK. Revolutionizing Pharmaceutical Research: Harnessing Machine Learning for a Paradigm Shift in Drug Discovery. International Journal of Multidisciplinary Sciences and Arts. 2023. doi:10.47709/IJMDSA.V2I2.2897
  • 19.   Irissarry C, Burger Helmchen T. Using Artificial Intelligence to Advance the Research and Development of Orphan Drugs. Businesses. 2024. doi:10.3390/Businesses4030028
  • 20.   Jung YL, Yoo HS, Hwang J. Artificial intelligence-based decision support model for new drug development planning. Expert systems with applications. 2022. doi:10.1016/J. ESWA.2022.116825
  • 21.   Khadela A, Popat S, Ajabiya J, Valu D, Savale S, Chavda VP, et al. AI, ML and Other Bioinformatics Tools for Preclinical and Clinical Development of Drug Products. 2023. doi:10.1002/9781119865728.CH12
  • 22.   Kokudeva M, Vichev M, Naseva E, Miteva DG, Velikova T. Artificial intelligence as a tool in drug discovery and development. World Journal of Experimental Medicine. 2024. doi:10.5493/WJEM.V14.I3.96042.
  • 23.   Kolluri S, Lin J, Liu R, Zhang Y, Zhang W. Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a Review. AAPS Journal. 2022. doi:10.1208/ S12248-021-00644-3.
  • 24.   Koromina M, Pandi M, Patrinos GP. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics. Omics. 2019. doi:10.1089/ OMI.2019.0151.
  • 25.   Kumar M, Nguyen TPN, Kaur J, Singh TG, Soni D, Singh R, et al. Opportunities and challenges in application of artificial intelligence in pharmacology. Pharmacological Reports. 2023. doi:10.1007/S43440-022-00445-1
  • 26.   Lamberti MJ, Wilkinson M, Donzanti BA, Wohlhieter GE, Parikh S, Wilkins R, et al. A Study on the Application and Use of Artificial Intelligence to Support Drug Development. Clinical Therapeutics. 2019. doi:10.1016/J. CLINTHERA.2019.05.018
  • 27.   Liebman M. The Role of Artificial Intelligence in Drug Discovery and Development. Chemistry International. 2022. doi:10.1515/CI-2022-0105
  • 28.   Liu Y, Zhang L, Jiang Z, Xia T, Li P, Wu P, et al. Applications of Artificial Intelligence in Biotech Drug Discovery and Product Development. MedComm. 2025. doi:10.1002/MCO2.70317
  • 29.   Mak K, Pichika MR. Artificial intelligence in drug development: present status and future prospects. Drug Discovery Today. 2019. doi:10.1016/J.DRUDIS.2018.11.014
  • 30.   Malandraki-Miller S, Riley PR. Use of artificial intelligence to enhance phenotypic drug discovery. Drug Discovery Today. 2021. doi:10.1016/J.DRUDIS.2021.01.013.
  • 31.   Malheiro V, Santos B, Figueiras A, Mascarenhas‐Melo F. The Potential of Artificial Intelligence in Pharmaceutical Innovation: From Drug Discovery to Clinical Trials. Pharmaceuticals. 2025. doi:10.3390/ PH18060788.
  • 32.   Mohapatra M, Sahu C, Mohapatra S. Trends of Artificial Intelligence (AI) Use in Drug Targets, Discovery and Development: Current Status and Future Perspectives. Current Drug Targets. 2024. doi:10.2174/01138945013227342 41008163304.
  • 33.   Moingeon P, Kuenemann MA, Guedj M. Artificial intelligence-enhanced drug design and development: Toward a computational precision medicine. Drug Discovery Today. 2021. doi:10.1016/J.DRUDIS.2021.09.006.
  • 34.   Morishita EC, Nakamura S. Recent applications of artificial intelligence in RNA-targeted small molecule drug discovery. Expert Opinion on Drug Discovery. 2024. doi:10.1080/17460441.2 024.2313455.
  • 35.   Mottaghi-Dastjerdi N, Soltany Rezaee Rad M. Advancements and Applications of Artificial Intelligence in Pharmaceutical Sciences: A Comprehensive Review. Iranian journal of pharmaceutical research. 2024. doi:10.5812/ JPR-150510.
  • 36.   Nagasundaram N, Yee EYK, Le NQK, Kamaraj B, Al Subaie AM, Yeh H. Application of Computational Biology and Artificial Intelligence Technologies in Cancer Precision Drug Discovery. BioMed Research International. 2019. doi:10.1155/2019/8427042
  • 37.   Naik K, Goyal RK, Foschini L, Chak CM, Thielscher C, Zhu H, et al. Current Status and Future Directions: The Application of Artificial Intelligence/Machine Learning for Precision Medicine. Clinical pharmacology and therapy. 2023. doi:10.1002/CPT.3152.
  • 38.   Napolitano G, Has C, Schwerk A, Yuan JH, Ullrich C. Potential of Artificial Intelligence to Accelerate Drug Development for Rare Diseases. Pharmaceutical Medicine. 2024. doi:10.1007/S40290-023-00504-9.
  • 39.   Narayan A, Chanana A, Shanker O, Kulkarni YR, Gupta P, Patel A, et al. Role of Artificial Intelligence in Pharmaceutical Drug Development. Current Indian science. 2024. do i:10.2174/012210299X313252240521111358.
  • 40.   Niazi SK. The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives. Drug Design, Development and Therapy. 2023. doi:10.2147/DDDT.S424991
  • 41.   Niazi SK, Mariam Z. Artificial intelligence in drug development: reshaping the therapeutic landscape. Therapeutic Advances in Drug Safety. 2025. doi:10.1177/20420986251321704
  • 42.   Ocaña A, Pandiella A, Privat C, Bravo I, Luengo-Oroz M, Amir E, et al. Integrating artificial intelligence in drug discovery and early drug development: a transformative approach. Biomarker Research. 2025. doi:10.1186/S40364-025-00758-2.
  • 43.   Odah M. Artificial Intelligence Meets Drug Discovery: A Systematic Review on AI-Powered Target Identification and Molecular Design. 2025. doi:10.20944/Preprints202503.0912.V1
  • 44.   Paliwal A, Alam MdA, Sharma P, Jain S, Dhoundiyal S. Revolutionizing Cancer Research and Drug Discovery: The Role of Artificial Intelligence and Machine Learning. Current Cancer Therapy Reviews. 2024. doi:10. 2174/0115733947288355240305080236.
  • 45.   Parvathaneni M, Awol AK, Kumari M, Lan K, Lingam M. Application of Artificial Intelligence and Machine Learning in Drug Discovery and Development. Journal of Drug Delivery and Therapeutics. 2023. doi:10.22270/JDDT. V13I1.5867.
  • 46.   Pun FW, Ozerov IV, Zhavoronkov A. AIpowered therapeutic target discovery. TIPS - Trends in Pharmacological Sciences. 2023. doi:10.1016/J.TIPS.2023.06.010.
  • 47.   Qureshi R, Irfan M, Gondal TM, Khan S, Wu J, Hadi MU, et al. AI in drug discovery and its clinical relevance. Heliyon. 2023. doi:10.1016/J. Heliyon.2023.E17575.
  • 48.   Sahoo A, Dar GM. A comprehensive review on the application of artificial intelligence in drug discovery. 2021. doi:10.52679/ TABCJ.2021.0007.
  • 49.   Sampene AK, Nyirenda F. Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China. Future Journal of Pharmaceutical Sciences. 2024. doi:10.1186/S43094-024-00632-2.
  • 50.   Sarkar C, Das B, Rawat VS, Wahlang JB, Nongpiur A, Tiewsoh I, et al. Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development. International Journal of Molecular Sciences. 2023. doi:10.3390/ IJMS24032026.
  • 51.   Sarvepalli S, Vadarevu S. Role Of Artificial Intelligence In Cancer Drug Discovery And Development. Cancer Letters. 2025. doi:10.1016/J.Canlet.2025.217821.
  • 52.   Selvaraj C, Chandra I, Singh SK. Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries. Molecular diversity. 2021. doi:10.1007/S11030-021- 10326-Z.
  • 53.   Sharma A, Virmani T, Pathak V, Sharma A, Pathak K, Kumar G, et al. Artificial IntelligenceBased Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine. BioMed Research International. 2022. doi:10.1155/2022/7205241
  • 54.   Sharma P, Jain V, Tailang M. How Artificial Intelligence is Transforming Medicine: The Future of Pharmaceutical Research. Advanced technologies and societal change. 2023. doi:10.1007/978-981-99-1949-9_7
  • 55.   Sharma V, Singh AK, Chauhan S, Sharma PK, Chaudhary S, Sharma A, et al. Role of Artificial Intelligence in Drug Discovery and Target Identification in Cancer. Current Drug Delivery. 2023. doi:10.2174/1567201821666230 905090621
  • 56.   Shiammala PN, Duraimutharasan N, Vaseeharan B, Alothaim AS, Al Malki ES, Snekaa B, et al. Exploring the Artificial Intelligence and Machine Learning Models in the Context of Drug Design Difficulties and Future Potential for the Pharmaceutical Sectors. Methods. 2023. doi:10.1016/J. YMETH.2023.09.010
  • 57.   Singh S, Kumar R, Payra S, Singh SK. Artificial Intelligence and Machine Learning in Pharmacological Research: Bridging the Gap Between Data and Drug Discovery. Cureus. 2023. doi:10.7759/CUREUS.44359
  • 58.   Suriyaamporn P, Pamornpathomkul B, Patrojanasophon P, Ngawhirunpat T, Rojanarata T, Opanasopit P. The Artificial Intelligence-Powered New Era in Pharmaceutical Research and Development: A Review. AAPS PharmSciTech. 2024. doi:10.1208/S12249-024-02901-Y
  • 59.   T S, Ali HM, Kumar BV. AI - Driven Drug Discovery and Therapeutic Target Identification for Rare Genetic Diseases. 2024 International Conference on Advancements in Smart, Secure and Intelligent Computing (ASSIC). 2024. doi:10.1109/ASSIC60049.2024.10507989
  • 60.   Tiwari P, Pal R, Chaudhary MJ, Nath R. Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges. Drug development research (Print). 2023. doi:10.1002/DDR.22115
  • 61.   Unogwu OJ, Ike M, Joktan OO. Employing Artificial Intelligence Methods in Drug Development: A New Era in Medicine. Mesopotamian Journal of Artificial Intelligence in Healthcare. 2023. doi:10.58496/ MJAIH/2023/010
  • 62.   Vamathevan J, Clark DA, Czodrowski P, Dunham I, Ferrán EA, Lee G, et al. Applications of machine learning in drug discovery and development. Nature reviews Drug discovery. 2019. doi:10.1038/S41573-019-0024-5
  • 63.   Vidiyala N, Sunkishala P, Parupathi P, Nyavanandi D. The Role of Artificial Intelligence in Drug Discovery and Pharmaceutical Development: A Paradigm Shift in the History of Pharmaceutical Industries. AAPS PharmSciTech. 2025. doi:10.1208/S12249-025- 03134-3
  • 64.   Vora LK, Gholap AD, Jetha K, Singh TRR, Solanki HK, Chavda VP. Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. Pharmaceutics. 2023. doi:10.3390/Pharmaceutics15071916.
  • 65.   Wang B, Zhang T, Liu Q, Sutcharitchan C, Zhou Z, Zhang D, et al. Elucidating the role of artificial intelligence in drug development from the perspective of drug-target interactions. Journal of Pharmaceutical Analysis. 2024. doi:10.1016/J.JPHA.2024.101144
  • 66.   You Y, Lai X, Pan Y, Zheng H, Vera J, Liu S, et al. Artificial intelligence in cancer target identification and drug discovery. Signal Transduction and Targeted Therapy. 2022. doi:10.1038/S41392-022-00994-0
  • 67.   Zhang K, Yang X, Wang Y, Yu Y, Huang N, Li G, et al. Artificial intelligence in drug development. Nature Network Boston. 2025. doi:10.1038/S41591-024-03434-4

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

R. Vinoth, D. Senthil Rajan, A. Nandhini et al. Artificial Intelligence in Pharmaceutical Research and Development: From Target Identification to Clinical Applications. J Pharmaceut Med Chem. 2025; 11(2): 51-62.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
August 13, 2025 November 18, 2025 December 30, 2025

DOI: https://doi.org/10.21088/jpmc.2395.6615.11225.2

Keywords

Artificial IntelligencePharmaceutical ResearchDrug DevelopmentLead OptimizationMachine Learning

Article Level Metrics

Last Updated

Sunday 06 September 2026, 19:33:21 (IST)


1012

Accesses

9
100
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received August 13, 2025
Accepted November 18, 2025
Published December 30, 2025

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share